Graded exercise therapy does not restore the ability to work in ME/CFS - Rethinking of a Cochrane review.
Vink, Mark, Vink-Niese, Friso · Work (Reading, Mass.) · 2020 · DOI
Quick Summary
This study examined whether graded exercise therapy (GET)—a treatment that gradually increases physical activity—actually helps people with ME/CFS return to work. The researchers found that while previous reviews claimed GET improved tiredness, these claims were based on unreliable self-reported outcomes in studies with serious flaws. When looking at objective measures and real-world outcomes, GET did not help people work better and may have harmed at least half of patients.
Why It Matters
This analysis is critical because treatment recommendations for ME/CFS directly impact patient safety and quality of life. If a widely-endorsed treatment causes harm in half of patients without restoring function or work capacity, this represents a significant public health concern that warrants reassessment of clinical guidelines and research methodology standards in ME/CFS treatment trials.
Observed Findings
GET did not produce significant objective improvements in functional capacity or work-related outcomes despite claims of fatigue improvement.
Studies included in the Cochrane review had serious methodological flaws including poorly matched controls, outcome switching, and p-hacking.
Subjective fatigue improvements in non-blinded GET trials are unreliable and may reflect expectancy effects rather than true benefit.
Patient surveys report harm occurring in ≥50% of ME/CFS patients receiving GET.
The amended Cochrane review failed to adequately consider objective outcome data or evidence of harms.
Inferred Conclusions
Graded exercise therapy should not be recommended as a treatment for ME/CFS based on current evidence quality and failure to restore work capacity.
The evidence base for GET in ME/CFS is substantially weakened by methodological flaws and reliance on unreliable subjective outcomes in non-blinded designs.
Previous favorable conclusions about GET represent a misinterpretation of weak evidence and overlooking of harm signals.
Future ME/CFS research requires higher methodological standards, objective outcome measures, and genuine consideration of patient-reported harms.
Remaining Questions
What This Study Does Not Prove
This study does not prove that all forms of exercise are harmful for all ME/CFS patients, nor does it establish the optimal rehabilitation approaches for this population. It also does not demonstrate what effective treatments should be recommended instead, only that GET as currently studied and recommended does not achieve stated objectives. The study's conclusions about harm rely partly on patient surveys rather than exclusively on randomized trial data.